The Haystack Project
  • Home
  • About Us Participants Partners Board and Advisors
  • Priorities
  • PROTECT Rare
  • Rare Disease Approvals HEART Act
  • Speaker Series Payer Engagement Health Equity Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Blue-Banner.png
The Haystack Project

Medicare

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Featured
Haystack 6.10.24 IPPS Comment
Jun 12, 2024
Haystack 6.10.24 IPPS Comment
Jun 12, 2024
Jun 12, 2024
Haystack MA RFI Response 5.29.24
May 30, 2024
Haystack MA RFI Response 5.29.24
May 30, 2024
May 30, 2024
Haystack MPPP Model Documents Comment
May 1, 2024
Haystack MPPP Model Documents Comment
May 1, 2024
May 1, 2024
RFI on Improving and Protecting Access to Gene Therapies
Jan 25, 2024
RFI on Improving and Protecting Access to Gene Therapies
Jan 25, 2024
Jan 25, 2024
Medicare Prescription Payment Plan Guidance
Sep 20, 2023
Medicare Prescription Payment Plan Guidance
Sep 20, 2023
Sep 20, 2023
Haystack Comments on CMS Proposed Evidence Standards NCD
Aug 21, 2023
Haystack Comments on CMS Proposed Evidence Standards NCD
Aug 21, 2023
Aug 21, 2023
Haystack Comments CMS Proposal on CED
Aug 21, 2023
Haystack Comments CMS Proposal on CED
Aug 21, 2023
Aug 21, 2023
Haystack's Comments on Craft of bill on State Integrated Care Programs for Dual Eligible Individuals
Jul 3, 2023
Haystack's Comments on Craft of bill on State Integrated Care Programs for Dual Eligible Individuals
Jul 3, 2023
Jul 3, 2023
Haystack's  comments on CMS’ proposed rule on the Medicaid and Children’s Health Insurance Program (CHIP)
Jul 3, 2023
Haystack's comments on CMS’ proposed rule on the Medicaid and Children’s Health Insurance Program (CHIP)
Jul 3, 2023
Jul 3, 2023
Haystack comments on CMS' proposed rule to update IPPS
Jun 9, 2023
Haystack comments on CMS' proposed rule to update IPPS
Jun 9, 2023
Jun 9, 2023
Haystack IRA data elements ICR 5.22.23
May 22, 2023
Haystack IRA data elements ICR 5.22.23
May 22, 2023
May 22, 2023
Haystack's comments in response to CMS' Notice of proposed rulemaking on Advancing Interoperability & Improving Prior Authorization Processes
Mar 14, 2023
Haystack's comments in response to CMS' Notice of proposed rulemaking on Advancing Interoperability & Improving Prior Authorization Processes
Mar 14, 2023
Mar 14, 2023
Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance
Mar 13, 2023
Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance
Mar 13, 2023
Mar 13, 2023
Haystack's comments in response to CMS' Medicare Part D Inflation Rebate Guidance
Mar 11, 2023
Haystack's comments in response to CMS' Medicare Part D Inflation Rebate Guidance
Mar 11, 2023
Mar 11, 2023
Haystack's Comments on CMS Proposal to Oppose For Rare Diseases
Feb 13, 2023
Haystack's Comments on CMS Proposal to Oppose For Rare Diseases
Feb 13, 2023
Feb 13, 2023
Haystack's comments on CMS' RFI related to EHB under the ACA
Jan 30, 2023
Haystack's comments on CMS' RFI related to EHB under the ACA
Jan 30, 2023
Jan 30, 2023
Haystack's sign-on letter providing analysis of coverage with evidence development (CED) criteria
Jan 13, 2023
Haystack's sign-on letter providing analysis of coverage with evidence development (CED) criteria
Jan 13, 2023
Jan 13, 2023
Haystack's comments on improving coverage for individuals dully-eligible for Medicare and Medicaid
Jan 13, 2023
Haystack's comments on improving coverage for individuals dully-eligible for Medicare and Medicaid
Jan 13, 2023
Jan 13, 2023
Haystack Responds to CMS’ National Provider Directory RFI
Dec 6, 2022
Haystack Responds to CMS’ National Provider Directory RFI
Dec 6, 2022
Dec 6, 2022
Finance Democrats Call for More Consumer Protections in Medicare Advantage
Nov 28, 2022
Finance Democrats Call for More Consumer Protections in Medicare Advantage
Nov 28, 2022
Nov 28, 2022
Haystack Response to CMS' Make Your Voice Heard RFI
Nov 3, 2022
Haystack Response to CMS' Make Your Voice Heard RFI
Nov 3, 2022
Nov 3, 2022
Haystack signs on to Telehealth Stakeholder Letter to Senate
Sep 13, 2022
Haystack signs on to Telehealth Stakeholder Letter to Senate
Sep 13, 2022
Sep 13, 2022
Haystack Project highlights the need for well-meaning proposals to consider impact on rare patients.
Sep 6, 2022
Haystack Project highlights the need for well-meaning proposals to consider impact on rare patients.
Sep 6, 2022
Sep 6, 2022
Haystack Responds to HHS RFI on Improving Primary Care
Aug 1, 2022
Haystack Responds to HHS RFI on Improving Primary Care
Aug 1, 2022
Aug 1, 2022
Haystack Project's reply to CMS' Hospital Inpatient Prospective Payment Systems
Jun 17, 2022
Haystack Project's reply to CMS' Hospital Inpatient Prospective Payment Systems
Jun 17, 2022
Jun 17, 2022
Haystack Project's sign-on letter commenting to CMS' proposed NCA for monoclonal antibodies
Feb 10, 2022
Haystack Project's sign-on letter commenting to CMS' proposed NCA for monoclonal antibodies
Feb 10, 2022
Feb 10, 2022
Haystack Project Applauds Introduction of the Access to Rare Indications Act
Dec 7, 2021
Haystack Project Applauds Introduction of the Access to Rare Indications Act
Dec 7, 2021
Dec 7, 2021
Guidance on Coordinating Care Provided By Out-of-State Providers for Children with Medically Complex Conditions
Oct 20, 2021
Guidance on Coordinating Care Provided By Out-of-State Providers for Children with Medically Complex Conditions
Oct 20, 2021
Oct 20, 2021
Reasonable & Necessary
Oct 4, 2021
Reasonable & Necessary
Oct 4, 2021
Oct 4, 2021
Medicare Part D Out of Pocket Letter
Sep 9, 2021
Medicare Part D Out of Pocket Letter
Sep 9, 2021
Sep 9, 2021

 
 
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/

The Haystack Project

Act Now

Engage in our efforts to support Ultra Rare advocacy.

Act Now
 

Join Haystack Project

Get news and updates and engage in Ultra Rare advocacy. Sign up to join our community today.

Join Us
 

Keep up-to-date with current events at Haystack!

View past newsletters

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.